1 / 70

Figures replaced or skipped for Ch 2

Figures replaced or skipped for Ch 2. Figure 2.3 - Enzyme digestion of Ab’s Flow cytometry - Fig 2.13 Monoclonal Ab Fig 2.12 was replaced. Molecular and structural basis of antibody diversity How B cells develop and function in the body

Télécharger la présentation

Figures replaced or skipped for Ch 2

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Figures replaced or skipped for Ch 2 • Figure 2.3 - Enzyme digestion of Ab’s • Flow cytometry - Fig 2.13 • Monoclonal Ab Fig 2.12 was replaced

  2. Molecular and structural basis of antibody diversity • How B cells develop and function in the body • How B cells are activated and participate in adaptive immunity Chapter 2 Antibody Structure and the Generation of B-Cell Diversity

  3. Location and production of Immunoglobulins Humoral Immunity - immunity dominated by antibodies that can be transferred to another person Antibodies are specific for individual epitopes Membrane bound form is present on a B-cell Ag binding to B cell stimulates it to secrete Ab

  4. Antibody structure Fab Fc Heavy (5 classes), Light (2 classes), Constant (C) and Variable (V) Disulfide bonds link heavy chains Fab- fragment antigen binding Fc- fragment crystallizable

  5. Immunoglobulin Isotypes or Classes    pentamers N-linked carbohydrate Hinge region Disulfide bonds Monomer as BCR Multimeric forms k l-Light chain Ig domain   Monomers or dimers

  6. Figure 2-5 Immunoglobulin (Ig) domain ~100 amino acid domain - very stable Two types Ig domains- variable and constant Antigen Binding site - VH and VL Heavy chain of IgG - four domains - VH, CH1, CH2, CH3

  7. Figure 2-6 Anti-parallel -strands - contribute to the structural part Loop region - in the V domain contribute to variability

  8. Hypervariable Regions (CDR) of Antibodies HV - hypervariable regions CDR - complementarity determining regions Framework region -  strand region that has reduced variability

  9. Amino Acid Sequence Variability in the V domain 110 amino acid light-chain V domain Framework regions can have variability but variability is much higher in the HV regions

  10. Physical Properties of Antigens-Antibody Binding • Epitope - part of the antigen bound by Ab • Antigen is usually carbohydrate or protein • Lock and Key concept • Variety of structures and sizes recognized by Ab’s • Affinity vs Avidity - terms describing binding strength of an antibody for its epitope

  11. Epitopes • Epitope (antigenic determinant) is the part of the antigen bound by Ab • Most antigens have multiple epitopes (multivalent) • Usually carbohydrate or peptide. Fig. 2.9

  12. Mechanisms of Epitope Recognition • Linear and discontinuous epitopes • Multivalent Antigens • Polymeric Antibodies • Affinity vs Avidity - terms describing binding strength of an antibody for its epitope • Epitope binding mechanisms

  13. Figure 2-9

  14. Figure 2-26 part 1 of 2 First Ab to be made during during an immune response to an antigen Monomers disulfide bonded together via the J-chain (joining chain)

  15. Figure 2-30 Monomers disulfide bonded to the J-chain Dimeric in mucosal lymphoid tissue - secreted into the gut to prevent pathogens binding to gut cells and can act as an antitoxin Monomeric made by B-cells in lymph nodes/spleen and is not J-chain dependent

  16. Antibody-antigen interaction • Non-covalent binding: • Electrostatic • Hydrogen bonds • Van der Waals force • Hydrophobic forces • Affinity: Strength of interaction between epitope and one antigen-binding site • Avidity: Strength of the sum of interactions between antibody and antigen

  17. Figure 2-8 Poliovirus VP1- blue, contains several epitopes (white) that can be recognized by human antibodies

  18. Antibodies bind a Range of Structures Grooves Extended surfaces Pockets Molecule DNA Lysozyme

  19. Examples of Problematic Ab binding to various structures Pocket: Penicillin - can bind to RBC surface proteins to create a foreign epitope. IgE binds to drug-RBC protein complex and initiates an inflammatory response Groove: DNA - Systemic Lupus Erythematosus (Lupus) - autoimmune disease in which antibodies are made against DNA and other molecules leading to inflammatory reactions in joints, skin and kidney Extended Surface: Lysozyme/Ovalbumin - allergies to hen egg components - more common in children under 5 - “desensitization” protocol can help

  20. Haptens Small molecules that are not immunogenic by themselves, but can bind immunoglobulins or TCRs. Haptens can induce an immune response when linked to a larger protein.

  21. 3 4 1 2 Polyclonal vs Monoclonal Antibodies 1 Ag 4 2 Isolate B-cells Spleen Myeloma cells Hybridoma Cells 3 1 2 + 4 3 1 2 3 4 Isolate serum Ab-1 Ab-2 Ab-3 Ab-4 Polyclonal antibodies 1 Ag 4 2 Monoclonal antibodies Ab-1, Ab-2 Ab-3, Ab-4 3

  22. Crossreactivity Occurs when an Antiserum is raised against antigen A but also reacts with antigen B Antigen A and B share epitopes Antigen A and B have similar (but not identical) epitopes

  23. Antibody Structure Summary • Produced by B-cells • Y shape, Four polypeptide chains, Ig domains • Constant and Variable regions • 5 classes - IgG, IgM, IgD, IgA, IgE • CDR, Hypervariable regions • Epitope recognition

  24. Examples of Commercial uses for Ab’s • Pregnancy test • Rh disease therapy • Antitoxin serum - Antivenin, rabies, etc • Anti-cancer monoclonals - will be covered later in the course

  25. Pregnancy test Pregnancy window Control window Input window Reaction zone Urine Mouse Monoclonal anti-HCG Ab-enzyme conjugate Immobile Polyclonal anti-HCG Ab + dye substrate Immobile Goat Anti-mouse Ab + dye substrate http://mcb.berkeley.edu/courses/mcb150/lecture5/Preg%20Test%20movie.swf

  26. Rh disease Rh disease (Erythroblastosis Fetalis) - Hemolytic disease of a newborn - occurs in Rh- woman carrying Rh+ fetus RhoGAM - human plasma with anti-Rh+ (D antigen) antibodies. Works by binding any fetal RBC’s before the mother is able to produce an immune response and form anti-D IgG

  27. Antitoxin serum • Serum can be used in the prophylaxis and/or treatment of rabies, botulism, diphtheria, gas gangrene, snake and spider bites • Antivenin Crotalidae Polyvalent (ACP) - horse serum based antivenom - gold standard for snake bites but can cause “serum sickness” • New types of antitoxins • Fragmented antivenin (CroFab) where only the Fab fragment (sheep-based) is used • Humanized antibodies derived from mouse sources

  28. Generation of Ig diversity in B cells Unique organization - Only B cells can express Ig protein - Gene segments k l-Light chain , , , ,  - Heavy Chain present on three chromosomes

  29. The Gene Rearrangement Concept • Germline configuration • Gene segments need to be reassembled for expression • Sequentially arrayed • Occurs in the B-cells precursors in the bone marrow (soma) • A source of diversity BEFORE exposure to antigen

  30. V-variable, J-joining, D-diversity gene segments; L-leader sequences Light Chain Variable - V, J Constant - C Heavy Chain Variable - V, D, J Constant - C

  31. Figure 2-14 Gene rearrangements during B-cell development V-variable, J-joining, D-diversity gene segments; L-leader sequences l - 30 V & 4 pairs J & C (light chain) chs22 k – 40 V & 5 J & 1 C (50% have 2x V) (light chain) chs2 H – 65 V & 27 D & 6 J chs14

  32. V-region of light chain consists of one V and one J segment C-region is encoded by one C segment Variability comes from the V segment CDR1 and CDR2 CDR3

  33. D-diversity CDR1 and CDR2 CDR3 Two recombination events needed to combine 3 segments to make the Variable region

  34. Random Recombination of Gene segments is one factor contributing to diversity + 120*) 10,530 = 3,369,600 Ig molecules (200* X * Only one light chain loci gives rise to one functional polypeptide!

  35. Mechanism of Recombination • Recombination signal sequences (RSSs) direct recombination • V and J (L chain) • V D J (H chain) • RSS types consist of: - nonamer (9 base pairs) • - heptamer (7 base pairs) • - Spacer • Two types: [7-12-9], [7-23-9] • RSS features: - recognition sites for recombination enzymes - recombination occurs in the correct order (12/23 rule)

  36. Mechanism of Somatic Recombination • V(D)J recombinase: all the protein components that mediate the recombination steps • RAG complex: Recombination Activating Genes (RAG-1 and RAG-2) encode RAG proteins only made in lymphocytes • Recombination only occurs through two different RSS bound by two RAG complexes (12/23 rule) • DNA cleavage occurs to form a single stranded hairpin and a break at the heptamer sequences • Enzymes that cut and repair the break introduce Junctional Diversity

  37. Junctional Diversity Recombination + http://www.blink.biz/immunoanimations/#

  38. Figure 2-19

  39. Figure 2-18 part 2 of 3 Junctional Diversity • Nucleotides introduced at recombination break in the coding joint corresponding to CDR3 of light and heavy chains - V and J of the light chain - (D and J) or (V and DJ) of the heavy chain • P nucleotides generate short palindromic sequences • N nucleotides are added randomly - these are not encoded • Junctional Diversity contributes 3 x107 to overall diversity!

  40. Generation of BCR (IgD and IgM) • Rearrangement of VDJ of the heavy chain brings the gene’s promoter closer to C and C • Both IgD and IgM are expressed simultaneously on the the surface of the B cell as BCR - ONLY isotypes to do this • Alternative splicing of the primary transcript RNA generates IgD and IgM • Naïve B cells are early stage B cells that have yet to see antigen and produce IgD and IgM

  41. Figure 2-21 Alternative Splicing of Primary Transcript to generate IgM or IgD

  42. Summary Biosynthesis of IgM in B cells

  43. Figure 2-23 Mature B cell • Long cytoplasmic tails interact with intracellular signaling proteins • Disulfide-linked • Ig and Ig - invariant - Transmembrane proteins - Dual-function • help the assembled Ig reach the cell surface from the ER • signal the B cell to divide and differentiate

  44. Principle of Single Antigen Specificity • Each B cell contains two copies of the Ig locus (Maternal and Paternal copies) • Only one is allowed to successfully rearrange - Allelic Exclusion • All Igs on the surface of a single B cell have identical specificity and differ only in their constant region • Result: B cell monospecificity means that a response to a pathogen can be very specific l k H * * 2 14 Chromosome 22

  45. DNA hybridization of Ig genes can diagnose B-cell leukemias Peripheral blood from healthy patient is made up of mostly neutrophils Peripheral blood from a leukemia patient has an abnormally high proportion of B-cells. Cancer cells are derived from one clonal line of B-cell which has V and C chains rearranged next to each other

  46. Generation of B cell diversity in Ig’s before Antigen Encounter • Random combination of V and J (L chain) and V, D, J (H chain) regions • Junctional diversity caused by the addition of P and N nucleotides • Combinatorial association of Light and Heavy chains (each functional light chain is found associated with a different functional heavy chain and vice versa)

  47. Concept of Combinatorial Association

  48. Developmental stages of B cells 1. Development before antigen 2. Development after antigen Mature naive B cell (expressing BCR - IgM and IgD) Immature B cell plasma cell (expressing BCR and secretes Antibodies)

More Related